23 May 2013
Keywords: alexion, pexelizumab, fails, main, trial, goal, released
Article | 11 August 2003
Alexion has released disappointing preliminary findings from a large, multinational Phase III trial of its pexelizumab, a cardiovascular
agent being ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 July 2003
21 July 2003
8 September 2003
© 2013 thepharmaletter.com